InsiderClue
← All stocks

Xenon Pharmaceuticals Inc.

XENE Mostly scheduled
CIK 0001582313 #1255 in the set updated 17 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$22.97M
$3.26M on a plan · $19.07M straight out of an exercise
Sold at will
$640.55K
1 of 27 sales
Net
−$22.97M
−$640.55K against sales at will

By person

11 insiders · 29 transactions
1.5×

Ian Mortimer holds only 1.5 times base salary in stock. $1.21M of shares against $786.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Ian Mortimer last reported holding, valued at $60.98, the price Common Shares was last bought or sold at on the open market here, on 28 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
MORTIMER IAN
PRESIDENT & CEO
—
$21.30M (18) scheduled
−$21.30M
19,923
0.0206%
$1.21M
−36.4%
KENNEY CHRISTOPHER JOHN
Chief Medical Officer
—
$670.26K (4) scheduled
−$670.26K
2
<0.0001%
$121.95
+100.0%
GANNON STEVEN
Director
—
$640.55K (1)
−$640.55K
1,870
0.0019%
$114.03K
−6.5%
DiFabio Andrea
Chief Legal Officer
—
$230.81K (2) scheduled
−$230.81K
7,301
0.0075%
$445.19K
—
PATOU GARY
Director
—
$70.25K (1) scheduled
−$70.25K
24,896
0.0257%
$1.52M
+5.6%
Cannon Gillian
Director
—
$63.24K (1) scheduled
−$63.24K
1,455
0.0015%
$88.72K
—
Svoronos Dawn
Director
—
—
—
31,373
0.0324%
$1.91M
+25.5%
Machado Patrick
Director
—
—
—
2,645
0.0027%
$161.28K
—
Gover Justin D.
Director
—
—
—
2,645
0.0027%
$161.28K
—
GAROFALO ELIZABETH A.
Director
—
—
—
2,645
0.0027%
$161.28K
—
AULIN SHERRY
Chief Financial Officer
—
—
—
0
0.0000%
$0.00
—

Individual transactions

14
Insider
Date
Role
Action
Shares
Price
Amount
KENNEY CHRISTOPHER JOHN
28 Aug 2026
Chief Medical Officer
Sold on a plan
700
$60.98
$42.68K
KENNEY CHRISTOPHER JOHN
28 Aug 2026
Chief Medical Officer
Sold on a plan
6,368
$60.17
$383.15K
Cannon Gillian
5 Jun 2026
Director
Sold on a plan
1,190
$53.14
$63.24K
PATOU GARY
5 Jun 2026
Director
Sold on a plan
1,322
$53.14
$70.25K
MORTIMER IAN
13 Mar 2026
PRESIDENT & CEO
Sold on a plan
7,308
$55.23
$403.58K
DiFabio Andrea
13 Mar 2026
Chief Legal Officer
Sold on a plan
1,342
$55.23
$74.11K
KENNEY CHRISTOPHER JOHN
13 Mar 2026
Chief Medical Officer
Sold on a plan
1,410
$55.23
$77.87K
MORTIMER IAN
10 Mar 2026
PRESIDENT & CEO
Sold on a plan
11,269
$60.11
$677.36K
DiFabio Andrea
10 Mar 2026
Chief Legal Officer
Sold on a plan
2,607
$60.11
$156.70K
KENNEY CHRISTOPHER JOHN
10 Mar 2026
Chief Medical Officer
Sold on a plan
2,771
$60.11
$166.56K
MORTIMER IAN
8 Dec 2025
PRESIDENT & CEO
Sold on a plan
2,010
$46.32
$93.10K
MORTIMER IAN
8 Dec 2025
PRESIDENT & CEO
Sold on a plan
8,820
$45.59
$402.10K
MORTIMER IAN
5 Dec 2025
PRESIDENT & CEO
Sold on a plan
14,375
$45.03
$647.31K
MORTIMER IAN
28 Nov 2025
PRESIDENT & CEO
Sold on a plan
97
$45.01
$4.37K
Show all 29 transactions →

What was left out

Form 4 filings counted 28
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 14
Sales straight out of an exercise 12
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 419,991
History held since 27 Sep 2016